Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATG, Cy, and Cord Blood in Severe Aplastic Anemia
NCT02838992Phase 4Unknown
- Sponsor
- 960th Hospital
- Start
- Feb 2017
- Primary completion
- Dec 2018
- Modality
- Stem Cell Therapies, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cyclophosphamide, hematopoietic progenitor cells, cord blood in aplastic anemia, sponsored by 960th Hospital. Status: unknown.
02
Drugs
cyclophosphamidehematopoietic progenitor cells, cord blood
03
Conditions
aplastic anemia
Beyond the preview
Go deeper on NCT02838992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02838992.